Form 8-K - Current report:
SEC Accession No. 0000950170-25-009474
Filing Date
2025-01-28
Accepted
2025-01-28 07:11:34
Documents
57
Period of Report
2025-01-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sabs-20250128.htm   iXBRL 8-K 47215
2 EX-99.1 - PRESS RELEASE OF THE COMPANY, DATED JANUARY 28, 2025 sabs-ex99_1.htm EX-99.1 29951
3 EX-99.2 - PRESENTATION OF THE COMPANY, DATED JANUARY 28, 2025 sabs-ex99_2.htm EX-99.2 34957
4 GRAPHIC img1871078_0.jpg GRAPHIC 371950
5 GRAPHIC sabs-ex99_2s1.jpg GRAPHIC 231192
6 GRAPHIC sabs-ex99_2s2.jpg GRAPHIC 251251
7 GRAPHIC sabs-ex99_2s3.jpg GRAPHIC 568737
8 GRAPHIC sabs-ex99_2s4.jpg GRAPHIC 239381
9 GRAPHIC sabs-ex99_2s5.jpg GRAPHIC 251588
10 GRAPHIC sabs-ex99_2s6.jpg GRAPHIC 427662
11 GRAPHIC sabs-ex99_2s7.jpg GRAPHIC 318143
12 GRAPHIC sabs-ex99_2s8.jpg GRAPHIC 293146
13 GRAPHIC sabs-ex99_2s9.jpg GRAPHIC 274979
14 GRAPHIC sabs-ex99_2s10.jpg GRAPHIC 379948
15 GRAPHIC sabs-ex99_2s11.jpg GRAPHIC 389836
16 GRAPHIC sabs-ex99_2s12.jpg GRAPHIC 334115
17 GRAPHIC sabs-ex99_2s13.jpg GRAPHIC 509989
18 GRAPHIC sabs-ex99_2s14.jpg GRAPHIC 394751
19 GRAPHIC sabs-ex99_2s15.jpg GRAPHIC 388125
20 GRAPHIC sabs-ex99_2s16.jpg GRAPHIC 384018
21 GRAPHIC sabs-ex99_2s17.jpg GRAPHIC 460590
22 GRAPHIC sabs-ex99_2s18.jpg GRAPHIC 706491
23 GRAPHIC sabs-ex99_2s19.jpg GRAPHIC 236240
24 GRAPHIC sabs-ex99_2s20.jpg GRAPHIC 299937
25 GRAPHIC sabs-ex99_2s21.jpg GRAPHIC 357211
26 GRAPHIC sabs-ex99_2s22.jpg GRAPHIC 277834
27 GRAPHIC sabs-ex99_2s23.jpg GRAPHIC 289202
28 GRAPHIC sabs-ex99_2s24.jpg GRAPHIC 274264
29 GRAPHIC sabs-ex99_2s25.jpg GRAPHIC 367240
30 GRAPHIC sabs-ex99_2s26.jpg GRAPHIC 274506
31 GRAPHIC sabs-ex99_2s27.jpg GRAPHIC 314690
32 GRAPHIC sabs-ex99_2s28.jpg GRAPHIC 568190
33 GRAPHIC sabs-ex99_2s29.jpg GRAPHIC 487319
34 GRAPHIC sabs-ex99_2s30.jpg GRAPHIC 349445
35 GRAPHIC sabs-ex99_2s31.jpg GRAPHIC 388268
36 GRAPHIC sabs-ex99_2s32.jpg GRAPHIC 335148
37 GRAPHIC sabs-ex99_2s33.jpg GRAPHIC 391678
38 GRAPHIC sabs-ex99_2s34.jpg GRAPHIC 360326
39 GRAPHIC sabs-ex99_2s35.jpg GRAPHIC 352059
40 GRAPHIC sabs-ex99_2s36.jpg GRAPHIC 320544
41 GRAPHIC sabs-ex99_2s37.jpg GRAPHIC 462796
42 GRAPHIC sabs-ex99_2s38.jpg GRAPHIC 398063
43 GRAPHIC sabs-ex99_2s39.jpg GRAPHIC 376460
44 GRAPHIC sabs-ex99_2s40.jpg GRAPHIC 446337
45 GRAPHIC sabs-ex99_2s41.jpg GRAPHIC 448651
46 GRAPHIC sabs-ex99_2s42.jpg GRAPHIC 376981
47 GRAPHIC sabs-ex99_2s43.jpg GRAPHIC 246692
  Complete submission text file 0000950170-25-009474.txt   22552708

Data Files

Seq Description Document Type Size
48 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sabs-20250128.xsd EX-101.SCH 47154
59 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20250128_htm.xml XML 6620
Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 25560903
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)